A randomized, multicentre, openlabel, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing /remitting multiple sclerosis - Mikol, D (Multiple Sclerosis, 2005)
et al.